Velan Capital Investment Management
Latest statistics and disclosures from Velan Capital Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are HRTX, CDTX, TARA, RZLT, PRAX, and represent 42.09% of Velan Capital Investment Management's stock portfolio.
- Added to shares of these 10 stocks: ABVX (+$5.5M), ZOOZ, LNTH, NSPR, JSPR, HRTX, EPRX, RAPT, SNDX, TRVI.
- Started 11 new stock positions in ABVX, ARWR, EPRX, RAPT, ZOOZ, TRVI, QURE, SNDX, DTIL, IMNM. LNTH.
- Reduced shares in these 10 stocks: TRML (-$19M), VRNA (-$9.0M), ZVRA (-$6.3M), ARVN, SCPH, LQDA, ALMS, CATX, Nektar Therapeutics, UPB.
- Sold out of its positions in ARVN, FDMT, CATX, ZVRA, KPRX, LQDA, Nektar Therapeutics, NXTC, SCPH, UPB. VRNA, VYNE.
- Velan Capital Investment Management was a net seller of stock by $-19M.
- Velan Capital Investment Management has $107M in assets under management (AUM), dropping by 5.15%.
- Central Index Key (CIK): 0001848809
Tip: Access up to 7 years of quarterly data
Positions held by Velan Capital Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Velan Capital Investment Management
Velan Capital Investment Management holds 49 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Heron Therapeutics (HRTX) | 10.4 | $11M | +25% | 8.8M | 1.26 |
|
| Cidara Therapeutics Com New (CDTX) | 9.8 | $10M | +8% | 108k | 95.76 |
|
| Protara Therapeutics Com Stk (TARA) | 8.7 | $9.3M | 2.1M | 4.35 |
|
|
| Rezolute Com New (RZLT) | 6.6 | $7.1M | 750k | 9.40 |
|
|
| Praxis Precision Medicines I Com New (PRAX) | 6.6 | $7.0M | -11% | 133k | 53.00 |
|
| Mineralys Therapeutics (MLYS) | 6.3 | $6.7M | 176k | 37.92 |
|
|
| Jasper Therapeutics Com New (JSPR) | 5.8 | $6.2M | +86% | 2.7M | 2.32 |
|
| Abivax Sa Sponsored Ads (ABVX) | 5.1 | $5.5M | NEW | 64k | 84.90 |
|
| Inspiremd (NSPR) | 4.9 | $5.2M | +137% | 2.1M | 2.41 |
|
| Zooz Pwr Share (ZOOZ) | 4.0 | $4.3M | NEW | 2.0M | 2.14 |
|
| Alumis (ALMS) | 3.5 | $3.8M | -41% | 947k | 3.99 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 3.5 | $3.8M | NEW | 74k | 51.29 |
|
| Avalo Therapeutics Com New (AVTX) | 3.1 | $3.4M | +70% | 264k | 12.71 |
|
| Sutro Biopharma (STRO) | 2.5 | $2.7M | 3.1M | 0.87 |
|
|
| Eupraxia Pharmaceuticals (EPRX) | 2.0 | $2.1M | NEW | 352k | 5.90 |
|
| Rapt Therapeutics Com New (RAPT) | 1.9 | $2.1M | NEW | 80k | 25.79 |
|
| Syndax Pharmaceuticals (SNDX) | 1.9 | $2.0M | NEW | 130k | 15.38 |
|
| Trevi Therapeutics (TRVI) | 1.8 | $1.9M | NEW | 205k | 9.15 |
|
| Uniqure Nv SHS (QURE) | 1.8 | $1.9M | NEW | 32k | 58.37 |
|
| Miragen Therapeutics (VRDN) | 1.8 | $1.9M | 87k | 21.58 |
|
|
| Edesa Biotech Com New (EDSA) | 1.6 | $1.7M | 688k | 2.47 |
|
|
| Tela Bio (TELA) | 1.0 | $1.1M | 747k | 1.49 |
|
|
| Eledon Pharmaceuticals (ELDN) | 0.8 | $899k | +2% | 347k | 2.59 |
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.7 | $772k | +3% | 61k | 12.65 |
|
| Tenax Therapeutics Com New (TENX) | 0.6 | $634k | 83k | 7.61 |
|
|
| Tourmaline Bio (TRML) | 0.3 | $277k | -98% | 5.8k | 47.83 |
|
| Cytomx Therapeutics (CTMX) | 0.2 | $255k | +6% | 80k | 3.19 |
|
| Protagonist Therapeutics (PTGX) | 0.2 | $246k | 3.7k | 66.43 |
|
|
| Arrowhead Pharmaceuticals (ARWR) | 0.2 | $224k | NEW | 6.5k | 34.49 |
|
| Ovid Therapeutics (OVID) | 0.2 | $208k | 160k | 1.30 |
|
|
| Gossamer Bio (GOSS) | 0.2 | $184k | -6% | 70k | 2.63 |
|
| Alector (ALEC) | 0.2 | $163k | 55k | 2.96 |
|
|
| Design Therapeutics (DSGN) | 0.1 | $151k | 20k | 7.53 |
|
|
| Terns Pharmaceuticals (TERN) | 0.1 | $150k | 20k | 7.51 |
|
|
| Nurix Therapeutics (NRIX) | 0.1 | $148k | +60% | 16k | 9.24 |
|
| Erasca (ERAS) | 0.1 | $142k | 65k | 2.18 |
|
|
| Ventyx Biosciences (VTYX) | 0.1 | $124k | 40k | 3.11 |
|
|
| Pyxis Oncology Common Stock (PYXS) | 0.1 | $122k | +37% | 55k | 2.22 |
|
| Immunome (IMNM) | 0.1 | $117k | NEW | 10k | 11.71 |
|
| Precision Biosciences Com New (DTIL) | 0.1 | $110k | NEW | 20k | 5.52 |
|
| Wave Life Sciences SHS (WVE) | 0.1 | $110k | 15k | 7.32 |
|
|
| Geron Corporation (GERN) | 0.1 | $110k | +14% | 80k | 1.37 |
|
| Larimar Therapeutics (LRMR) | 0.1 | $107k | 33k | 3.23 |
|
|
| Context Therapeutics (CNTX) | 0.1 | $97k | 100k | 0.97 |
|
|
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $96k | 45k | 2.13 |
|
|
| Replimune Group (REPL) | 0.1 | $84k | -89% | 20k | 4.19 |
|
| Immix Biopharma (IMMX) | 0.1 | $73k | +40% | 35k | 2.09 |
|
| Aclaris Therapeutics (ACRS) | 0.1 | $62k | 33k | 1.90 |
|
|
| Pmv Pharmaceuticals (PMVP) | 0.0 | $49k | 35k | 1.40 |
|
Past Filings by Velan Capital Investment Management
SEC 13F filings are viewable for Velan Capital Investment Management going back to 2021
- Velan Capital Investment Management 2025 Q3 filed Nov. 14, 2025
- Velan Capital Investment Management 2025 Q2 filed Aug. 14, 2025
- Velan Capital Investment Management 2025 Q1 filed May 15, 2025
- Velan Capital Investment Management 2024 Q4 filed Feb. 14, 2025
- Velan Capital Investment Management 2024 Q3 filed Nov. 14, 2024
- Velan Capital Investment Management 2024 Q2 filed Aug. 14, 2024
- Velan Capital Investment Management 2024 Q1 filed May 14, 2024
- Velan Capital Investment Management 2023 Q3 filed Nov. 13, 2023
- Velan Capital Investment Management 2023 Q2 filed Aug. 11, 2023
- Velan Capital Investment Management 2023 Q1 filed May 15, 2023
- Velan Capital Investment Management 2022 Q4 filed Feb. 13, 2023
- Velan Capital Investment Management 2022 Q3 filed Nov. 14, 2022
- Velan Capital Investment Management 2022 Q2 filed Aug. 15, 2022
- Velan Capital Investment Management 2022 Q1 filed May 16, 2022
- Velan Capital Investment Management 2021 Q4 filed Feb. 14, 2022